Primary Source Records · Source Documents
NIH COVID-19 Research (covid19.nih.gov)
The NIH’s own public account of what it was funding and finding during the pandemic: the trials, the treatment research, the testing programmes and what the agency said it knew at the time. Contemporaneous official statements are the first thing anyone re-litigating the pandemic will want and the first thing to disappear. The host no longer resolves in DNS. 58 pages are held here, recovered from the Internet Archive.
- Period
- 2021
- Region
- United States
- Language
- English
- Rights
- Public domain. A work of the United States Government is not subject to copyright under 17 U.S.C. § 105, so it is held in full with no exception claimed and none needed. Published by National Institutes of Health at covid19.nih.gov, where the host no longer resolves in DNS as last checked on 2026-09-22.
- Source
- https://covid19.nih.gov/
Full text
NIH COVID-19 RESEARCH (COVID19.NIH.GOV) National Institutes of Health
Captured from the Internet Archive on 2026-09-22. covid19.nih.gov no longer resolves in DNS. This file holds 58 pages, the most substantial the Archive has for that host. It is a capture of a site, not a complete mirror of it: pages the Archive never visited are not here, and neither are images, downloads or anything the site generated for a logged-in visitor. Each page is headed with its title, its address and its capture date.
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Mental%20Health&page=1 — captured 2024-07-19
How COVID-19 Has Affected Communities on the Gulf Coast
Alcohol Use During the COVID-19 Pandemic
Researchers Identify Four Long COVID Categories
Teen Brains Aged Prematurely During COVID-19 Pandemic
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=All&page=1 — captured 2024-04-25
Home Test to Treat Program Expands Nationwide
Shining a Light on Long COVID Brain Fog
Common Cold Virus May Increase Risk for Long COVID
SARS-CoV-2 Infection May Increase Risk of Heart Disease, Stroke
Severe COVID-19 May Cause Long-Term Immune System Changes
SARS-CoV-2 Antibodies From Vaccination During Pregnancy May Transfer to Fetuses
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=All — captured 2024-04-25
Home Test to Treat Program Expands Nationwide
Shining a Light on Long COVID Brain Fog
Common Cold Virus May Increase Risk for Long COVID
SARS-CoV-2 Infection May Increase Risk of Heart Disease, Stroke
Severe COVID-19 May Cause Long-Term Immune System Changes
SARS-CoV-2 Antibodies From Vaccination During Pregnancy May Transfer to Fetuses
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Treatment&page=1 — captured 2024-04-25
The Long-Term Effects of SARS-CoV-2 on Organs and Energy
A Mental Wellness Project Supports Students During COVID-19
NIH Launches Clinical Trials for Long COVID Treatments
Can A Diabetes Treatment Reduce the Risk of Long COVID?
Delivering Extra Protection Against COVID-19
The Impact of Opioid Use Disorder Services on Overdose Deaths
COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list=Mental%20Health&page=1 — captured 2024-07-12
LONG COVID
Information about Long COVID symptoms, management, and clinical trials supported by NIH
MENTAL HEALTH
The latest information on mental health during the COVID-19 pandemic
SEARCH NIH COVID-19 ARTICLES AND RESOURCES
Scroll down the page to view all COVID-19 articles, stories, and resources from across NIH. You can also select a topic from the list to view resources on that topic.
Mental Health Support and COVID-19
Discover tips and resources for coping with the pandemic’s effects on mental health.
Support for the Autism Community
Learn about challenges that individuals with autism and their families face during the pandemic.
Coping With COVID-19
Access shareable graphics, social media messages, and links to articles and other COVID-19 resources.
Long COVID | NIH COVID-19 Research covid19.nih.gov/covid-19-topics/long-covid?mibextid=Zxz2cZ — captured 2023-01-26
On This Page: -->
- What Is Long COVID?
- Symptoms of Long COVID
- What We Know About Long COVID
- How You Can Help Fight Long COVID
- Long COVID Resources
Symptoms of COVID-19 can last months — or even longer — after infection with SARS-CoV-2, the virus that causes COVID-19. Symptoms vary from person to person and can affect almost any part of the body.
Many people recover fully within a few days or weeks after being infected with SARS-CoV-2, the virus that causes COVID-19. But others have symptoms that linger for weeks, months, or even years after their initial diagnosis. Some people seem to recover from COVID-19 but then see their symptoms return, or they develop new symptoms within a few months. Even people who had no symptoms when they were infected can develop symptoms later. Either mild or severe COVID-19 can lead to long-lasting symptoms.
Long COVID, long-haul COVID, post-COVID-19 condition, chronic COVID, and post-acute sequelae of SARS-CoV-2 (PASC) are all names for the health problems that some people experience within a few months of a COVID-19 diagnosis. Symptoms of Long COVID may be the same or different than symptoms of COVID-19 . Long COVID can also trigger other health conditions, such as diabetes or kidney disease.
Click on any hotspot on the human body to learn more about Long COVID symptoms.
- Whole Body
- Brain and Nerves
- Eyes
- Ears
- Smell and Taste
- Neck
- Lungs
- Heart and Blood
- Kidneys
- Hands
- Legs and Feet
- Reproductive Systems
- Digestive Systems
- Skin and Hair
- Muscles and Bones
Back
- Tiredness or a lack of energy that interferes with daily life
- Symptoms that get worse after physical or mental activity
- Fever and chills
- Sleep problems including insomnia, extreme daytime sleepiness, and restless leg syndrome
- Weakness
- Brain fog (problems with thinking, concentrating, remembering, and learning)
- Headaches
- Dizziness upon standing
- Mood symptoms (feeling sad, stressed, tense, or angry) that interfere with daily life
- Mental health conditions such as anxiety, depression, or post-traumatic stress disorder
- Tingling, numbness, and nerve damage
- Seizures
- Changes in vision
- Eye redness
- Yellowish eyes (jaundice, a symptom of liver disease)
- Hearing loss
- Stuffy nose
- Loss of taste or distorted sense of taste
- Loss of smell or distorted sense of smell
- Loss of appetite
- Increased thirst (a symptom of diabetes triggered by COVID-19)
- Neck pain that spreads toward the ears (from a swollen thyroid gland)
- Shortness of breath
- Cough
- Cough that may produce mucus from lungs
- Chest pain
- Rapid or irregular heartbeat
- Fainting
- Pain on the side of the body (symptom of kidney problems)
- Changes in urination
- Shaking
- Swelling in legs or feet
- Erectile dysfunction
- Changes in menstrual cycle
- Short-term reduced male fertility
- Stomach pain
- Changes in appetite
- Diarrhea
- Constipation
- Changes in stool color
- Rashes
- Hair loss
- Yellowish skin (jaundice, a symptom of liver damage)
- Muscle aches
- Joint pain
- Reduced mobility
COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list=Treatment&page=2 — captured 2023-03-21
NIH Plans Research on “Long COVID”
The new PASC Initiative will look at long-term symptoms of COVID-19.
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
Saving Lives in the ICU
New device could help prevent or treat multiple organ failure
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Vaccine&page=1 — captured 2024-03-05
RECENT NEWS & STORIES
February 14, 2024 | News Release
COVID-19 Vaccination, Boosters During Pregnancy Protect Infants for 6 Months
January 5, 2024 | Story
Home Test to Treat Program Expands Nationwide
January 2, 2024 | Story
Shining a Light on Long COVID Brain Fog
Variant in Immune Gene Linked to Lack of Symptoms During COVID-19
Booster Vaccine Targeting Omicron Offers Broader COVID-19 Protection
COVID-19 Reduces Immune Response to COVID-19 Vaccines
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Substance%20Use%20Disorder — captured 2023-12-11
Risky Alcohol Use: An Epidemic Inside the COVID-19 Pandemic
COVID-19 Testing Hits the Road in West Virginia
Seeing the Pandemic Through Adolescent Eyes (and Brains)
COVID-19, the Opioid Crisis, and the Risk of HIV Infection
COVID-19: Potential Implications for Individuals With Substance Use Disorders
Substance Use Disorders and COVID-19
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Vaccine — captured 2023-12-11
Variant in Immune Gene Linked to Lack of Symptoms During COVID-19
Booster Vaccine Targeting Omicron Offers Broader COVID-19 Protection
COVID-19 Reduces Immune Response to COVID-19 Vaccines
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Children — captured 2023-12-11
A Mental Wellness Project Supports Students During COVID-19
Obstructive Sleep Apnea May Increase Risk of Long COVID
Biomarkers Found in Children with Rare COVID-19 Complication
Exposure to COVID-19 In Utero May Affect Birth Weight
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Aging — captured 2023-12-11
Understanding Sleep Problems and Long COVID
Understanding Cognitive Symptoms of COVID-19 in Older African Americans
Frequent COVID Testing Prevents Infections, Deaths in Nursing Facilities
Rapid Progression of Dementia Following COVID-19
Study Looks at Older Adults With Chronic Conditions During COVID-19
How COVID-19 Affects Nursing Homes and People With Dementia
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Pregnancy — captured 2023-12-11
Exposure to COVID-19 In Utero May Affect Birth Weight
Evaluating the Safety of COVID-19 Treatment During Pregnancy
How Does COVID-19 During Pregnancy Affect Child Development?
How COVID-19 and Community Violence Affect Mothers and Babies
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Testing — captured 2023-12-11
Device Detects Loss of Smell After COVID-19
Frequent COVID Testing Prevents Infections, Deaths in Nursing Facilities
Smart Masks May Help Detect COVID-19 and Future Infections
Tracking COVID-19 Through Wastewater
COVID-19 Testing Helps Keep Kids in School
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Mental%20Health — captured 2023-12-11
How COVID-19 Has Affected Communities on the Gulf Coast
Alcohol Use During the COVID-19 Pandemic
Researchers Identify Four Long COVID Categories
Teen Brains Aged Prematurely During COVID-19 Pandemic
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Clinical%20Trial — captured 2023-12-11
Understanding Sleep Problems and Long COVID
NIH Launches Clinical Trials for Long COVID Treatments
Can A Diabetes Treatment Reduce the Risk of Long COVID?
What Long COVID Looks Like in Children and Young Adults
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Minorities — captured 2023-12-11
Understanding Cognitive Symptoms of COVID-19 in Older African Americans
Symptoms of Long COVID Vary Between Racial and Ethnic Groups
Tracking COVID-19 Through Wastewater
Antiviral Treatment Reduces Likelihood of Severe Illness From Omicron
COVID-19 DATASETS FOR RESEARCHERS
Find COVID-19 datasets, data tools, and publications to use in research.
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Treatment — captured 2023-12-11
A Mental Wellness Project Supports Students During COVID-19
NIH Launches Clinical Trials for Long COVID Treatments
Can A Diabetes Treatment Reduce the Risk of Long COVID?
Delivering Extra Protection Against COVID-19
The Impact of Opioid Use Disorder Services on Overdose Deaths
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Immune%20Responses — captured 2023-12-11
Severe COVID-19 May Cause Long-Term Immune System Changes
SARS-CoV-2 Antibodies From Vaccination During Pregnancy May Transfer to Fetuses
The Long-Term Effects of SARS-CoV-2 on Organs and Energy
Understanding Sleep Problems and Long COVID
How the Gut Microbiome Could Predict COVID-19 Severity
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Long%20COVID — captured 2023-12-11
Understanding Sleep Problems and Long COVID
How the Gut Microbiome Could Predict COVID-19 Severity
NIH Launches Clinical Trials for Long COVID Treatments
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Cancer — captured 2023-12-11
Teen Brains Aged Prematurely During COVID-19 Pandemic
Breaking Down the Body’s Response to SARS-CoV-2
COVID-19 Information for Cancer Researchers
COVID-19: Information for Cancer Patients
Home | NIH COVID-19 Research covid19.nih.gov/?topic_list=Nutrition — captured 2023-12-11
How the Gut Microbiome Could Predict COVID-19 Severity
Food Allergies and COVID-19
Dietary Supplements in the Time of COVID-19
====================================================================== Home | NIH COVID-19 Research covid19.nih.gov?sm_guid=MzI1MDMxfDIyNjM3ODcyfC0xfGpsYWdveUByZXNlYXJjaGFtZXJpY2Eub3JnfDI1OTE3MjB8fDB8MHwxNzgzMjM2Njh8OTUzfDB8MHx8MjkwNzY2fDA1 — captured 2023-09-25 ======================================================================
September 12, 2023
Story
Understanding Sleep Problems and Long COVID
September 6, 2023
More Evidence That COVID-19 Vaccination While Pregnant Likely Protects Children
September 1, 2023
How the Gut Microbiome Could Predict COVID-19 Severity
Home | NIH COVID-19 Research covid19.nih.gov?cid=eb_govdel — captured 2023-05-31
May 25, 2023
News Release
Large Study Provides Deeper Insight Into Long COVID Symptoms
Home | NIH COVID-19 Research covid19.nih.gov/?page=1 — captured 2023-06-02
May 25, 2023
News Release
Large Study Provides Deeper Insight Into Long COVID Symptoms
Home | NIH COVID-19 Research covid19.nih.gov/?_escaped_fragment_=/detail/403327 — captured 2023-05-23
May 12, 2023
Rare Organ Inflammation Now Less Serious for Children with COVID-19
COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list=Children&page=2 — captured 2023-05-25
COVID-19: The Ripple Effects
A new NIH working group hopes to understand and reduce social, behavioral, and economic health problems caused by the pandemic…
COVID-19 and Special Populations
Explore information about how COVID-19 may affect pregnant women, children, and underserved populations.
Long COVID | NIH COVID-19 Research covid19.nih.gov/covid-19-topics/long-covid — captured 2022-08-11
On This Page: -->
- What Is Long COVID?
- Symptoms of Long COVID
- What We Know About Long COVID
- How You Can Help Fight Long COVID
- Long COVID Resources
Symptoms of COVID-19 can last months — or even longer — after infection with SARS-CoV-2, the virus that causes COVID-19. Symptoms vary from person to person and can affect almost any part of the body.
Many people recover fully within a few days or weeks after being infected with SARS-CoV-2, the virus that causes COVID-19. But others have symptoms that linger for weeks, months, or even years after their initial diagnosis. Some people seem to recover from COVID-19 but then see their symptoms return, or they develop new symptoms within a few months. Even people who had no symptoms when they were infected can develop symptoms later. Either mild or severe COVID-19 can lead to long-lasting symptoms.
Long COVID, long-haul COVID, post-COVID-19 condition, chronic COVID, and post-acute sequelae of SARS-CoV-2 (PASC) are all names for the health problems that some people experience within a few months of a COVID-19 diagnosis. Symptoms of long COVID may be the same or different than symptoms of COVID-19 . Long COVID can also trigger other health conditions, such as diabetes or kidney disease.
Click on any hotspot on the human body to learn more about Long COVID symptoms.
- Whole Body
- Brain and Nerves
- Eyes
- Ears
- Smell and Taste
- Neck
- Lungs
- Heart and Blood
- Kidneys
- Hands
- Legs and Feet
- Reproductive Systems
- Digestive Systems
- Skin and Hair
- Muscles and Bones
Back
- Tiredness or a lack of energy that interferes with daily life
- Symptoms that get worse after physical or mental activity
- Fever and chills
- Sleep problems including insomnia and restless leg syndrome
- Weakness
- Brain fog (problems with thinking, concentrating, and remembering)
- Mental health conditions such as anxiety, depression, and mood changes
- Dizziness upon standing
- Headaches
- Seizures
- Tingling or numbness
- Nerve damage
- Changes in vision
- Eye redness
- Yellowish eyes (jaundice, a symptom of liver disease)
- Hearing loss
- Loss of taste or distorted sense of taste
- Loss of smell or distorted sense of smell
- Increased thirst (a symptom of diabetes triggered by COVID-19)
- Neck pain that spreads toward the ears (from a swollen thyroid gland)
- Shortness of breath
- Cough
- Chest pain
- Rapid or irregular heartbeat
- Fainting
- Pain on the side of the body (symptom of kidney problems)
- Changes in urination
- Shaking
- Swelling in legs or feet
- Erectile dysfunction
- Changes in menstrual cycle
- Short-term reduced male fertility
- Stomach pain
- Changes in appetite
- Diarrhea
- Constipation
- Changes in stool color
- Rashes
- Hair loss
- Yellowish skin (jaundice, a symptom of liver damage)
- Muscle aches
- Joint pain
- Reduced mobility
COVID-19 Vaccines | NIH COVID-19 Research covid19.nih.gov/covid-19-topics/covid-19-vaccines — captured 2022-04-28
On This Page: -->
- Understanding COVID-19 Vaccine Studies
- COVID-19 Vaccine Resources
UNDERSTANDING COVID-19 VACCINES
WHICH COVID-19 VACCINES ARE AVAILABLE IN THE UNITED STATES?
As of February 2022, two COVID-19 vaccines have been approved by the U.S. Food and Drug Administration (FDA), and one has been authorized for emergency use.
- Pfizer, Inc., and BioNTech BNT162b2: On August 23, 2021, the FDA approved the Pfizer-BioNTech vaccine — called Comirnaty — for people age 16 and older. The vaccine is still available under emergency use authorization for children and teens 5 to 15 years old. View the infographic to see what is in the Pfizer COVID-19 vaccine.
- ModernaTX, Inc., mRNA-1273: On January 31, 2022, the FDA approved this NIH-funded COVID-19 vaccine — called Spikevax — for people age 18 and older. View the infographic to see what is in the Moderna COVID-19 vaccine.
- Janssen Pharmaceutical Companies of Johnson & Johnson: On February 27, 2021, the FDA authorized emergency use of this single-shot vaccine for people age 18 and older. Developed with support from NIH, this vaccine does not require special refrigeration. Women younger than 50 years old should be aware of the rare risk of blood clots after vaccination.
WILL I NEED A BOOSTER SHOT?
Studies show that protection against SARS-CoV-2 begins to decrease over time after initial vaccine doses. Additional vaccine doses ( booster vaccinations ) provide longer-lasting protection against COVID-19.
The FDA has authorized booster vaccinations of all three COVID-19 vaccines available in the United States. The eligibility period for a booster dose is based on several factors, including which vaccine you originally received and how long it has been since you were fully vaccinated.
Eligible people can choose which vaccine they receive as a booster dose — this is known as heterologous or “mix and match” dosing . Based on data from the National Institute of Allergy and Infectious Diseases, the FDA has determined that the benefits of mixing doses outweighs any known or potential risks.
DO THE VACCINES WORK?
Studies show that COVID-19 vaccines are very effective in preventing COVID-19 , even for people at high risk for the disease.
Sometimes people who are fully vaccinated get a breakthrough infection , meaning that they test positive for SARS-CoV-2 or become ill with COVID-19. Fully vaccinated people are less likely to become seriously ill , even from COVID-19 variants.
HOW DO I KNOW THE VACCINES ARE SAFE?
Vaccines have very high safety standards, and COVID-19 vaccines are no exception. COVID-19 vaccines have undergone and will continue to undergo the most intensive safety monitoring in U.S. history.
The timeline for creating COVID-19 vaccines was shorter than for other vaccines for many reasons, including:
- NIH scientists have been studying mRNA vaccines and coronaviruses for decades . They had a head start because they already knew a lot about how mRNA vaccines work and how to make them.
- Researchers, the federal government, and drug companies came together like never before to cooperate and share resources, making the vaccine testing process more efficient.
- NIH set up the COVID-19 Prevention Network (CoVPN) to coordinate existing research networks and carry out large clinical trials in tens of thousands of people efficiently. Many Americans from diverse communities volunteered to participate in the studies.
- The FDA analyzed data from the clinical trials right away.
The safety of the authorized COVID-19 vaccines is being tracked through the Vaccine Adverse Event Reporting System , a unique safety system called v-safe that was established specifically for COVID-19 vaccines, and other systems. Vaccine manufacturers submit monthly safety updates to the FDA. The FDA also inspects vaccine production facilities and checks the quality of vaccine batches.
THE JOURNEY OF A VACCINE
Learn about the four phases of clinical research, what questions researchers try to answer in each, and how a vaccine is developed, approved, and manufactured.
DO THE VACCINES PROTECT AGAINST VIRUS VARIANTS?
Studies and current data show that the antibodies our bodies make after vaccination recognize and protect against COVID-19 variants . This is being closely investigated, and more studies are underway.
The rise of these variants is a reminder that as long as SARS-CoV-2 continues to spread, it has the potential to evolve into new variants. Widespread vaccination will help reduce the rise of additional variants.
WHEN CAN CHILDREN GET A VACCINE?
Children and teens age 5 and older can now get the Pfizer COVID-19 vaccine. Eligible children age 12 and older can also receive a booster dose of the Pfizer vaccine. It is currently the only COVID-19 vaccine authorized for people younger than 18. However, clinical trials are underway to test the safety and effectiveness of all currently available vaccines in younger children.
DO THE VACCINES HAVE ANY SIDE EFFECTS?
All vaccines may cause some side effects , which are normal signs that your body is making antibodies. These side effects go away in a few days. Many people have no side effects.
Serious side effects that could cause long-term health problems are extremely unlikely following any vaccination, including COVID-19 vaccination. These rare side effects usually appear within six weeks of receiving a vaccine dose. If you have any health problems after vaccination, report them to the Vaccine Adverse Event Reporting System (VAERS).
Rare cases of heart inflammation have been reported after mRNA COVID-19 vaccination, mainly in male adolescents and young adults.
The CDC continues to recommend vaccination for everyone 5 years of age and older, given the greater risk of serious complications related to COVID-19.
HOW COVID-19 AFFECTS PREGNANCY
Should you get the vaccine during pregnancy? Does the vaccine cause infertility? NIH research is helping to answer these questions and more.
HOW DO I GET A COVID-19 VACCINE?
The federal government is providing FDA-authorized COVID-19 vaccines free to all people living in the United States, regardless of their immigration or health insurance status. Search vaccines.gov , text your ZIP code to 438829, or call 1-800-232-0233 to find COVID-19 vaccine locations near you. Contact your state health department to find additional vaccination locations in your area.
If you have difficulty reaching a vaccination site, you may be able to get an in-home vaccination. Check a list of services that may offer in-home COVID-19 vaccinations in your area .
SHOULD I GET A VACCINE IF I'VE HAD COVID-19 IN THE PAST?
Studies indicate that vaccination produces a stronger immune response than the one produced by COVID-19 infection. The benefits of vaccination after infection far outweigh any known or potential risks.
To ensure that people who recover from COVID-19 are protected from getting the disease again, the CDC recommends that they get vaccinated . The timing of vaccination depends on when a person had COVID-19 and whether and when they received treatment. If you have had COVID-19 and want to be vaccinated, talk to your doctor about when you should get the vaccine.
ARE VACCINES STILL BEING RESEARCHED?
New and ongoing studies on vaccines are underway. NIH Institutes and Centers, in partnership with private businesses, continue to study different types of vaccines.
Some current research aims to determine whether approved vaccines will grant immunity against emerging COVID-19 variants and whether new vaccines will be needed. Other vaccine studies continue to monitor the health of people who have already had a vaccine to determine their effectiveness over a longer period of time.
NIH has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen. The trial also will investigate whether pausing immunosuppressive therapy for autoimmune disease could improve the antibody response for people who are receiving that additional vaccine dose.
HHS shares information about the vaccine distribution process.
The CDC shares information to answer common questions about vaccine safety.
Learn what to expect when you volunteer for a vaccine clinical trial.
Get the facts about COVID-19 vaccine studies.
RECENT NEWS
March 31, 2022
NIH Begins Clinical Trial Evaluating Second COVID-19 Booster Shot in Adults
March 28, 2022
The Story of the Pandemic in Washtenaw County
March 14, 2022
More Evidence That COVID-19 Vaccines Do Not Cause Infertility
March 9, 2022
NIH Launches Trial to Study Allergic Reactions to COVID-19 mRNA Vaccine
Clinical Trials | NIH COVID-19 Research covid19.nih.gov/covid-19-topics/clinical-trials — captured 2022-05-03
On This Page: -->
- Understanding COVID-19 Clinical Trials
- Find a COVID-19 Clinical Trial
- Clinical Trial Resources
WHAT IS A CLINICAL TRIAL?
Clinical trials are medical research studies with volunteers. The purpose of the studies is to determine whether a new treatment or vaccine works and is safe for people to use. After researchers thoroughly test new treatments or vaccines in the lab to make sure they may benefit people, the most promising treatments move into clinical trials.
How clinical trials work and what happens in each phase
ARE THERE CLINICAL TRIALS TO STUDY LONG COVID?
Some people continue to experience symptoms long after they recover from their initial COVID-19 illness. This is called Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC). NIH is sponsoring research to understand more about how SARS-CoV-2 may cause problems in the long term, and to develop ways to treat or prevent these long-term effects.
NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative is launching multiple clinical trials to gather information about the long-term, ongoing health effects that some people experience after SARS-CoV-2 infection.
As part of RECOVER, the National Institute of Allergy and Infectious Diseases (NIAID) is supporting a long-term study to track up to 1,000 children and young adults who previously tested positive for COVID-19. The study will evaluate how COVID-19 affects their physical and mental health for the next three years.
WHY SHOULD I PARTICIPATE IN A CLINICAL TRIAL?
People participate in clinical trials for a variety of reasons. Consider joining a COVID-19 clinical trial if you want to:
- Make a difference and help end the COVID-19 pandemic
- Make sure COVID-19 vaccines and treatments will work for as many people as possible
- Help us return to work, school, and normal life
ARE CLINICAL TRIALS SAFE?
If you take part in a clinical trial, your safety will be protected . Every clinical researcher is required to monitor participants to make sure they’re safe. These safeguards are an essential part of the research.
- Before they begin, clinical trials must be approved by an institutional review board (IRB) . An IRB is made up of doctors, scientists, and people like you and is dedicated to making sure that study participants are not exposed to unnecessary risks.
- Many clinical trials are also closely supervised by a data and safety monitoring board (DSMB) . The DSMB is made up of experts on the trial’s targeted condition who periodically look at the results of the study as it is in progress. If the DSMB finds that the experimental treatment is not working or is harming participants, the board will recommend that the trial be stopped right away.
- People who join clinical trials must give informed consent . This means that they are told exactly what is going to happen, what the risks are, and what their rights are.
HOW DO I KNOW WHETHER A CLINICAL TRIAL IS REAL?
Clinical trials are very important, but not all of them are legitimate. If you’re interested in participating in a COVID-19 research study, the Federal Trade Commission has guidance to help you determine whether a clinical trial is real or fake .
COVID-19 CLINICAL TRIALS
This website shares a selected list of ongoing clinical trials for COVID-19 treatments and vaccines, as well as for people who have recovered from infection.
COMBATCOVID. HHS.GOV
This website provides more information about COVID-19 clinical trials.
CLINICALTRIALS.GOV
This searchable database shows federally and privately supported clinical trials studying COVID-19 in the United States and around the world.
The importance of participating in the CoVPN clinical trials.
Including people from every community is important in clinical research.
Learn about the importance of including communities of color in clinical trials.
Vaccines are tested through the different phases of clinical trials.
Participants and researchers share what taking part in a clinical trial is like.
RECENT NEWS
March 31, 2022
NIH Begins Clinical Trial Evaluating Second COVID-19 Booster Shot in Adults
March 28, 2022
The Story of the Pandemic in Washtenaw County
March 14, 2022
More Evidence That COVID-19 Vaccines Do Not Cause Infertility
March 9, 2022
NIH Launches Trial to Study Allergic Reactions to COVID-19 mRNA Vaccine
COVID-19 Treatments | NIH COVID-19 Research covid19.nih.gov/covid-19-topics/covid-19-treatments — captured 2022-04-29
On This Page: -->
- COVID-19 Treatments
- Questions About COVID-19 Treatments
- NIH COVID-19 Treatment Research
- COVID-19 Treatment Resources
AT HOME
You can treat mild symptoms of COVID-19 at home with over-the-counter medicine and reduce the chances of viral spread with basic safety steps. The Centers for Disease Control and Prevention has guidance for at-home treatment of COVID-19 .
FROM YOUR DOCTOR
The FDA has issued emergency use authorization for three COVID-19 treatments. Not everyone who gets COVID-19 qualifies to receive these treatments.
- The first treatment is monoclonal antibodies , which may help your immune system recognize and defend against COVID-19. It is only available at infusion centers.
- Another treatment is a combination of two tablets called Paxlovid ( nirmatrelvir and ritonavir ). The two medicines are taken together twice a day for five days. This treatment should be started as soon as possible after symptoms begin.
- The third treatment is a pill called molnupiravir . It is taken twice a day for five days and should be started as soon as possible after symptoms begin.
If you have COVID-19 and are at high risk of severe illness , your doctor may recommend monoclonal antibodies, nirmatrelvir and ritonavir, or molnupiravir. They may refer you to a clinical trial for a potential COVID-19 treatment . They may also prescribe medicine to help with your symptoms.
AT THE HOSPITAL
People with serious illness from COVID-19 should go to the hospital for treatment . The hospital may give treatments to:
- Slow the virus's spread through the body with antiviral medicines such as remdesivir.
- Calm the body’s immune system , which may overreact to the virus and worsen the disease. Overactive immune responses can damage organs and tissues.
- Treat complications to the body, such as in the heart, blood vessels, kidneys, and brain. COVID-19 can also cause other complications. Patients who are hospitalized with serious COVID-19 illness might also be given blood thinners to prevent or treat blood clots.
AVAILABLE COVID-19 TREATMENT OPTIONS
If you or a loved one tests positive for COVID-19, you may have treatment options.
IF COVID-19 IS TREATABLE, DO I NEED A VACCINE?
Preventing COVID-19 is more effective than treating it. Vaccines protect people from getting infected or from becoming severely ill, and masks and social distancing help keep the virus from spreading.
By getting vaccinated, you can also keep your loved ones safe. By wearing a mask and getting vaccinated, you are protecting the health of other people in your life and community who are at high risk of getting very sick or dying of COVID-19.
WHICH COVID-19 TREATMENTS ARE EFFECTIVE?
The FDA has approved or authorized several treatments for mild, moderate, and serious illness from COVID-19. There is a lot of misinformation online about COVID-19 treatments. Some proposed treatments have not been proven to be effective and could be dangerous. The U.S. Department of Health and Human Services (HHS) has more information on the available treatment options for COVID-19 .
COVID-19 TREATMENT GUIDELINES
The latest COVID-19 treatment guidelines, developed and updated regularly by a U.S. panel of experts.
NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative has accelerated research on treatments for COVID-19 across several different treatment types. Here is some of the current research.
DRUGS TO CALM THE IMMUNE SYSTEM
NIH is sponsoring studies to test the safety and effectiveness of immune modulators , which minimize the effects of an overactive immune system response that some COVID-19 patients experience. These studies aim to determine whether immune modulators can reduce the need for ventilators and shorten hospital stays.
ANTIBODIES TO LESSEN THE SEVERITY OF COVID-19
Clinical trials supported by NIH are being done to study the safety and effectiveness of monoclonal and polyclonal antibodies in both inpatient and outpatient settings. The studies are testing whether the treatments shorten the time to recovery and lessen respiratory and other problems from COVID-19 infection.
DRUGS TO PREVENT BLOOD CLOTTING AND TISSUE DAMAGE
NIH-supported studies aim to determine whether medicines called blood thinners can treat adults diagnosed with COVID-19 and prevent life-threatening blood clots from forming. These studies focus on people who are diagnosed with COVID-19 and are hospitalized, as well as those who are recovering from COVID-19.
TESTING MEDICINES ALREADY IN USE
Studies are currently enrolling people who are hospitalized with COVID-19 to test the effectiveness of several different medications that are in late-stage clinical development . Other trials will test whether medicines used to treat other conditions could help treat COVID-19 in people with mild to moderate symptoms.
TREATMENT RESOURCES
Monoclonal antibodies are being tested in NIH clinical trials as a potential treatment for COVID-19.
Learn how antibodies can be effective at preventing COVID-19, especially for people with compromised immune systems.
HHS shares information about treatment options and clinical trials for COVID-19.
Clinical trials offer hope for patients while helping researchers find better treatments.
RECENT NEWS
April 18, 2022
Understanding the Range of Reactions to SARS-CoV-2
April 11, 2022
Targeting COVID-19 Variants to Stop Infection Before It Begins
March 28, 2022
The Story of the Pandemic in Washtenaw County
February 17, 2022
Decoding the Genetics Behind COVID-19 Infection
COVID-19 Testing | NIH COVID-19 Research covid19.nih.gov/covid-19-topics/covid-19-testing — captured 2022-05-03
On This Page: -->
- COVID-19 Testing Basics
- The State of COVID-19 Testing
- COVID-19 Testing Resources
HOW DO I GET TESTED?
Most health care providers offer COVID-19 testing and should be contacted first if you are experiencing symptoms. Your state health department’s website will have information on additional local testing sites.
You can also schedule an appointment for a COVID-19 diagnostic test at many national pharmacy chains. Stores with drive-through lanes will ask you to remain in your car while a pharmacist guides you through the self-testing processes. Results are usually available in a few days.
WHAT SHOULD I DO IF I TEST POSITIVE FOR COVID-19?
Most people with COVID-19 have mild illness and can recover at home. You can help yourself recover and keep the virus from spreading within your family and to others by following the CDC guidelines for at-home COVID-19 care . If you are experiencing moderate to severe COVID-19 symptoms , talk to your doctor.
In March 2022, the White House launched the Test to Treat initiative to give people quick access to life-saving COVID-19 treatments. Hundreds of participating pharmacy-based clinics, community health centers, and long-term care facilities now provide free testing for COVID-19 and allow a person who tests positive at their site to be evaluated by a health care professional. If the treatments are right for them, they can be given antiviral medication right away. Find your closest Test to Treat site here or call 1-800-232-0233.
HOW CAN I GET AN AT-HOME TEST?
At-home rapid tests can be purchased over the counter at many pharmacies, with results ready in as little as 15 minutes. The CDC has more information about self-testing , including how to swab yourself.
Residential households in the U.S. can order free at-home tests from the U.S. Postal Service. Visit covidtests.gov to place an order.
More information on at-home tests and testing:
- The U.S. Food and Drug Administration (FDA) maintains a list of authorized at-home OTC COVID-19 diagnostic tests .
- The FDA has recalled Celltrion DiaTrust COVID-19 Ag Rapid Test (labeled for Research Use Only) over labeling issues. You can avoid getting a false result by not using these tests.
WHEN SHOULD I GET TESTED FOR COVID-19?
If you have been exposed to COVID-19, you should get tested — even if you have been vaccinated . Get tested for COVID-19:
- If you develop COVID-19 symptoms
- At least 5 days after known or suspected exposure to someone with COVID-19
- Before and after travel
- For screening by an employer, school, or other setting where lots of people gather
- If asked by a healthcare provider or public health official
WHAT ARE THE TYPES OF COVID-19 TESTS?
A viral test looks for current infection. There are two types of viral tests:
- The antigen test (also called the “rapid test”) gives results in as little as 15 minutes. You are more likely to get a false negative result from the antigen test. If you have symptoms but get a negative test result from the antigen test, your doctor may give you a molecular test to confirm the results.
- The molecular test can take a few days to a week to provide results. The most common test relies on a laboratory method called polymerase chain reaction (PCR) to detect SARS-CoV-2 genetic material.
An antibody test is designed to tell you whether you had an infection in the past.
WHY DO WE STILL NEED TESTING?
Testing is critical to controlling the spread of SARS-CoV-2, the virus that causes COVID-19. Testing is the only way to be sure you are not passing the virus on to others — even people who are vaccinated can carry the virus while showing few to no symptoms.
Testing also provides important information about the virus’s movement within and between communities. Public health officials need to know how many people are infected and where they live so that the officials can track outbreaks and react accordingly.
HOW IS NIH CONTINUING TO SUPPORT AND IMPROVE TESTING?
At the beginning of the pandemic, NIH moved quickly to support the development of fast and accurate testing, awarding nearly half a billion dollars through the RADx SM initiative to help rapidly scale up the country’s testing capacity.
Additional grants and research continue to support efforts to create easy-to-use tests, implement innovative ways of getting people tested, and reach underserved communities to ensure that anyone who needs a test can easily get one.
WHAT IS THE FUTURE OF TESTING?
NIH will continue to support research to make testing easier and more efficient. New testing devices and protocols are being developed and studied every day.
The Centers for Disease Control and Prevention (CDC) has created a test to determine whether a person’s respiratory infection is caused by SARS-CoV-2 or an influenza (flu) virus. These tests are available to physicians through public health departments and are most useful during cold and flu season.
The CDC shares information about testing and a COVID-19 symptoms checker.
The U.S. Food and Drug Administration shares facts about testing regulation and approval.
The U.S. Department of Health and Human Services (HHS) shares information about where and how to get tested.
The RADx-UP initiative provides communications toolkits in English and Spanish, including resources developed for American Indian tribes.
COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics — captured 2022-03-04
Understanding How Sex, Gender, and COVID-19 Intersect
The NIH Office of Research on Women’s Health (ORWH), the NIH Sexual & Gender Minority Research Office, and several NIH institutes and centers…
Decoding the Genetics Behind COVID-19 Infection
Researchers join forces to unravel a biological mystery
Finding Immune Clues to Severe COVID-19
Researchers have discovered 12 immune-related proteins that are associated with an increased risk of death from COVID-19.
Mixing and Matching COVID-19 Vaccine Booster Doses
The FDA has authorized the use of mix-and-match booster doses for currently available COVID-19 vaccines based on the results of a NIAID-supported…
How COVID-19 Affects Nursing Homes and People With Dementia
NIH networks are providing insight about COVID-19’s impact on adults age 65 and older
Do Some Babies Have a Higher Risk of Severe COVID-19?
Early data suggests that sex of the fetus affects amount of COVID-19 antibodies crossing the placenta
SARS-CoV-2 May Have Spread Faster, Sooner Than Previously Known
Two NIH-supported studies have found evidence of millions of undiagnosed cases of COVID-19 — some cases dating as far back as December 2019 —…
Understanding the Long-Term Effects of COVID-19 in Children
A long-term study of children’s health after COVID-19 infection has enrolled its first participants at the NIH Clinical Center in Maryland.
Finding Effective Treatments for SARS-CoV-2 Variants
Researchers analyze hundreds of antibodies to find more treatments for SARS-CoV-2 variants
How to Know When to Test for COVID-19
When To Test is a free online calculator that lets individuals and leaders of large organizations input their data and receive a detailed plan for…
What Happens When Children Are Hospitalized With COVID-19
Researchers uncover factors associated with ICU admission for children with COVID-19
Helping Latino-Owned Small Businesses Fight COVID-19
Community-based interventions help auto shops and beauty salons
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BAging%5D=Aging&topic_list%5BChildren%5D=Children&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-06 ======================================================================
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BAging%5D=Aging&topic_list%5BChildren%5D=Children&topic_list%5BTreatment%5D=Treatment&page=1 — captured 2022-03-06 ======================================================================
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BCancer%5D=Cancer&topic_list%5BChildren%5D=Children&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-11 ======================================================================
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BVaccine%5D=Vaccine&topic_list%5BLong%20COVID%5D=Long%20COVID&topic_list%5BNutrition%5D=Nutrition&page=1 — captured 2022-05-06 ======================================================================
Dietary Supplements in the Time of COVID-19
A summary of the science on the safety and efficacy of dietary supplements in the prevention and treatment of COVID-19.
Researching COVID to Enhance Recovery
An NIH initiative seeks to understand, prevent, and treat long-lasting health effects from COVID-19.
NIH Plans Research on “Long COVID”
The new PASC Initiative will look at long-term symptoms of COVID-19.
When COVID-19 Symptoms Linger
New NIH initiative seeks to understand why some people continue to have symptoms long after recovery.
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BClinical%20Trial%5D=Clinical%20Trial&topic_list%5BMinorities%5D=Minorities&page=1 — captured 2022-03-12 ======================================================================
Keeping Doctors Up to Date on COVID-19 Treatments
NIH expert panel revises treatment guidelines regularly based on the latest data.
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BTreatment%5D=Treatment&page=1 — captured 2022-03-12 ======================================================================
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-12 ======================================================================
Vouching for Vaccine Safety
People with a front-row seat on science share their perspective
How Kids Can Go Back to School Safely
Researchers are studying how COVID-19 testing can help get kids in school — and keep them there
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BCancer%5D=Cancer&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-11 ======================================================================
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BPregnancy%5D=Pregnancy&page=1 — captured 2022-03-12 ======================================================================
COVID-19 Vaccines and the Menstrual Cycle
NIH encourages researchers to investigate reported changes in menstruation after COVID-19 vaccination
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BClinical%20Trial%5D=Clinical%20Trial&topic_list%5BTesting%5D=Testing&page=1 — captured 2022-03-12 ======================================================================
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BClinical%20Trial%5D=Clinical%20Trial&topic_list%5BTreatment%5D=Treatment&page=1 — captured 2022-03-12 ======================================================================
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BCancer%5D=Cancer&topic_list%5BTesting%5D=Testing&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-12 ======================================================================
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BAging%5D=Aging&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BMinorities%5D=Minorities&page=1 — captured 2022-03-06 ======================================================================
NIH Plans Research on “Long COVID”
The new PASC Initiative will look at long-term symptoms of COVID-19.
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
Expanding Testing on Indian Reservations
Researchers study ways to encourage American Indians to seek tests
Community Engagement Alliance Against COVID-19 Disparities
Find communications tools and resources to support community engagement and outreach for people hardest hit by the pandemic.
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BTesting%5D=Testing&page=1 — captured 2022-03-12 ======================================================================
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BAging%5D=Aging&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BTesting%5D=Testing&page=1 — captured 2022-03-06 ======================================================================
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BAging%5D=Aging&topic_list%5BTreatment%5D=Treatment&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-11 ======================================================================
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BClinical%20Trial%5D=Clinical%20Trial&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-12 ======================================================================
COVID-19 Vaccination During Pregnancy Likely Benefits Moms and Babies
Natural transfer of antibodies may protect newborns
Vouching for Vaccine Safety
People with a front-row seat on science share their perspective
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BCancer%5D=Cancer&topic_list%5BTreatment%5D=Treatment&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-12 ======================================================================
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BChildren%5D=Children&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-05 ======================================================================
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BClinical%20Trial%5D=Clinical%20Trial&topic_list%5BPregnancy%5D=Pregnancy&page=1 — captured 2022-03-12 ======================================================================
COVID-19 Vaccines and the Menstrual Cycle
NIH encourages researchers to investigate reported changes in menstruation after COVID-19 vaccination
Keeping Doctors Up to Date on COVID-19 Treatments
NIH expert panel revises treatment guidelines regularly based on the latest data.
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BCancer%5D=Cancer&topic_list%5BChildren%5D=Children&topic_list%5BTreatment%5D=Treatment&page=1 — captured 2022-03-11 ======================================================================
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BAging%5D=Aging&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-06 ======================================================================
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
- Load More
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/COVID-19-Topics?topic_list%5BAging%5D=Aging&topic_list%5BTesting%5D=Testing&topic_list%5BVaccine%5D=Vaccine&page=1 — captured 2022-03-06 ======================================================================
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BSubstance%20Use%20Disorder%5D=Substance%20Use%20Disorder&page=1 — captured 2022-03-12 ======================================================================
IC14: A Force Field to Prevent COVID-19 Lung Damage?
NIH tests new antibody to stop severe immune responses
COVID-19, the Opioid Crisis, and the Risk of HIV Infection
A new study looks at the effects of interruptions to services for people with substance use…
Calming an Overactive Immune System
NIH-supported study is testing therapeutics to calm an excessive immune response.
====================================================================== COVID-19 Topics | NIH COVID-19 Research covid19.nih.gov/covid-19-topics?topic_list%5BChildren%5D=Children&topic_list%5BImmune%20Responses%5D=Immune%20Responses&topic_list%5BMinorities%5D=Minorities&page=1 — captured 2022-03-12 ======================================================================
- Load More
Preservation is not endorsement. The Free Knowledge Library preserves primary sources from across the political spectrum. Keeping a document does not mean we agree with it. What the labels mean.